New 3D bioprinting method can create organs from collagen
advertisement
Posição atual:
>
> This Story


Início de uma sessão ou Registo to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Cardiology Homepage

Key success criteria for the creation of an outpatient heart failure clinic Deb Thompson, senior consulting manager for Cardiology at Philips discusses what is required for the efficient management of a multi-disciplinary heart care team

New AI solution identifies high-risk patients from chest X-rays MGH tool may help detect heart disease, lung cancer

Cardiology occupies a unique space in medical informatics Looking at enterprise imaging and informatics through the lens of cardiology at SIIM

MiE showcases cardiac PET scanner, Ancoris, at SNMMI Provides simultaneous 3D cardiac PET perfusion and CFR

AI tool for Alexa and smart devices detects cardiac arrest in sleeping patients Monitors patients for agonal breathing

Mount Sinai surgeons first in NY to perform minimally-invasive heart bypass surgery Only for highly-skilled surgeons for now

New dye helps control 'lighting' for sharper images of heart May help identify early signs of heart disease

Evaluating the cost-effectiveness of AEDs in the U.S. Insights from Dr. Lars W. Andersen on research he conducted and what it should mean for the future of public defibrillators

The 2019 Heart Rhythm Society scientific sessions: advanced technology in electrophysiology Four key takeaways

New machine learning algorithm could decide who is best for heart failure treatment Could help prevent sudden death from heart failure

The new method enables 3D
printed tissues to be designed
with collagen

New 3D bioprinting method can create organs from collagen

por John R. Fischer , Staff Reporter
Providers may soon be able to offer patients 3D implants with tissues composed of collagen — the major structural protein in the human body.

Researchers at Carnegie Mellon University have developed a first-of-its-kind technique called FRESH (Freeform Reversible Embedding of Suspended Hydrogels) for designing and composing implants with the protein, based on MR scans of the desired organ. The method is touted by its creators as a step in the direction of developing full-sized, 3D printed, adult human hearts.

Story Continues Below Advertisement

Servicing GE/Siemens Nuclear Medicine equipment with OEM trained engineers

Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.



"What we've shown is that we can print pieces of the heart out of cells and collagen into parts that truly function, like a heart valve or a small beating ventricle," said Adam Feinberg, a professor of biomedical engineering (BME) and materials science and engineering at Carnegie Mellon, whose lab performed this work, in a statement. "By using MR data of a human heart, we were able to accurately reproduce patient-specific anatomical structure and 3D bioprint collagen and human heart cells."

Organs such as the heart rely on an extracellular matrix to hold the specialized cells that compose them together by providing structure and biochemical signals that enable the cells to carry out normal functions. Traditional biofabrication methods, however, are unable to rebuild these complex ECM networks.

The aim behind the method is to produced bioengineered organs that more closely replicate natural structures within the body, compared to current implants. This is especially important for heart transplants, which more than 4000 U.S. patients require. Millions worldwide also require them but are ineligible for waiting lists.

The FRESH 3D bioprinting method deposits collagen layer-by-layer with a support bath of gel, allowing the collagen to solidify in place before being removed from the support bath. The support gel is easily melted away by heating it from room to body temperature following the completion of the print, enabling researchers to remove it without damaging the printed structure made of collagen or cells.

The method, however, is not limited only to collagen and can be carried out with a range of soft gels, such as fibrin, alginate, and hyaluronic acid. The designs are also open-source, enabling all levels of expertise from medical labs to high school classes to build low-cost, high-performance 3D bioprinters.

Since its establishment, the method has enabled researchers to overcome many challenges faced in 3D printing today, and to achieve high resolution and fidelity using soft and living materials. Feinberg believes it could bring many applications to a variety of areas, from wound repair to organ bioengineering.

"Really what we're talking about is the convergence of technologies," he said. "Not just what my lab does in bioprinting, but also from other labs and small companies in the areas of stem cell science, machine learning, and computer simulation, as well as new 3D bioprinting hardware and software. It is important to understand that there are many years of research yet to be done, but there should still be excitement that we're making real progress toward engineering functional human tissues and organs, and this paper is one step along that path."

Cardiology Homepage


You Must Be Logged In To Post A Comment